Insider filing · BBTX
Helmut Wolfgang Jeggle
Director
profile →
Bambusa Therapeutics, Inc. Common stock
BBTX · Healthcare · 3 filings in 24 months
ticker →
Helmut Wolfgang Jeggle bought $6.0M of Bambusa Therapeutics (BBTX)
Executed Nov 2, disclosed Nov 2, the same day.
Value, as filed
$6.0M
375,000 sh × $16.00
Executed
Nov 2
the trade date, as filed
Disclosed
Nov 2
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
not yet measured
Not yet measured: the 21-session window has not closed, or the prices around it are not on record.
The filer
HJHelmut Wolfgang Jeggle (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Bambusa Therapeutics, Inc. Common stock (BBTX). The largest single filing was $6.0M of BBTX (375,000 sh × $16.00, as filed), executed Nov 2. The median gap between execution and disclosure was 0 days.
The name
BBTXHealthcare · Bambusa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops long-acting bispecific antibodies for the treatment of imm…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→